Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Letter to the Editor: Conclusions regarding relative cost-utility of alternative strategies for use of aromatase inhibitors in postmenopausal women with early breast cancer are premature

Letter to the Editor: Conclusions regarding relative cost-utility of alternative strategies for use of aromatase inhibitors in postmenopausal women with early breast cancer are premature. Annals of Oncology. 2007; 18(1):197-198, author reply 198-9.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.